Sapir Pharmaceuticals
New Jersey, US · Founded 2017 · Delaware corporation
Founders & leadership
SS
Samuel SternheimNamed on SEC filing
LS
Leonard SternheimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$450K disclosed across 1 round · 2017
▶$450KraisedFeb 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$450KraisedFeb 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Samuel SternheimExecutive Officer, Director, Promoter
- Leonard SternheimExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $450K
- Minimum investment
- $10K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sapir Pharmaceuticals raised?
- Sapir Pharmaceuticals has disclosed $450K raised across 1 round.
- Where is Sapir Pharmaceuticals headquartered?
- Sapir Pharmaceuticals is headquartered in New Jersey, US.